PlumX Metrics
Embed PlumX Metrics

SUSTAINED REDUCTION IN URINARY CALCIUM DURING LONG-TERM TREATMENT WITH SLOW RELEASE NEUTRAL POTASSIUM PHOSPHATE IN ABSORPTIVE HYPERCALCIURIA

The Journal of Urology, ISSN: 0022-5347, Vol: 159, Issue: 5, Page: 1451-1456
1998
  • 16
    Citations
  • 0
    Usage
  • 9
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    16
    • Citation Indexes
      12
    • Policy Citations
      3
      • Policy Citation
        3
    • Clinical Citations
      1
      • PubMed Guidelines
        1
  • Captures
    9

Article Description

We tested whether UroPhos § §Mission Pharmacal, San Antonio, Texas. -K a new slow release neutral form of potassium phosphate (155 mg. phosphate, 8 mEq. potassium per tablet) in a dose of 4 tablets twice daily absorptive hypercalciuria, a major cause of nephrolithiasis characterized by excessive intestinal calcium absorption accompanied in some patients by excessive bone loss.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know